OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Neurology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	88
Update on management of cerebral venous thrombosis	57
The recent surge of functional movement disorders: social distress or greater awareness?	53
Management of neuropsychiatric symptoms in dementia	50
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	49
The role of the gut microbiome in Alzheimer's disease pathophysiology	44
Neurosyphilis in 2025: Erratum	43
Editorial introductions	43
Central nervous system adverse events of immune checkpoint inhibitors	38
From basic mechanisms to therapeutic perspectives in cluster headache	37
Historical development and contemporary use of neuromodulation in human spinal cord injury	34
Neurology education in the era of artificial intelligence	32
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	31
Gene therapies for CMT neuropathies: from the bench to the clinic	31
Hereditary motor neuropathies	30
Microglia in multiple sclerosis – pathogenesis and imaging	30
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	28
Editorial introductions	27
Updates in neuro-otology	26
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	24
Editorial: Epilepsy advances in 2023	24
Connecting tremors – a circuits perspective	23
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	22
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms	22
Multiple sclerosis in China: the current state of diagnosis and management	22

Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial	22
Thymectomy in myasthenia gravis	21
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	21
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	21
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	21
Nerve ultrasound in the diagnosis of inflammatory neuropathies	21
Threat of resurgence or hope for global eradication of poliovirus?	21
Clinical impact of molecular profiling in rare brain tumors	21
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	20
Migraine in women: a review	20
The FSHD jigsaw: are we placing the tiles in the right position?	20
Levodopa infusion therapies for Parkinson disease	20
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1	20
Acute stroke care in low and middle-income countries	19
Red flags in multiple sclerosis	19
Gauging and controlling excitability in cortical disorders	19
Idiopathic intracranial hypertension: expanding our understanding	19
Electrical stimulation of the peripheral and central vestibular system	18
Obesity-related neuropathy: the new epidemic	18
fMRI-based spatio-temporal parcellations of the human brain	18
MRI for the diagnosis of limb girdle muscular dystrophies	18
Update on dermatomyositis	17
Parkinson's disease – genetic cause	17
Diet and migraine: what is proven?	17
New developments in diagnostics and treatment of adult-onset focal dystonia	17
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	16
Targeting IDH1/IDH2 mutations in gliomas	16
Neurosyphilis in 2025	16
Editorial: The gap between academic advances and therapy development in motor neuron disease	16
Novel approaches to treatment of leptomeningeal metastases	16
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	16
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	15
Progress in spinal muscular atrophy research	15
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	15
Neuroinflammation and immunometabolism in neurodegenerative diseases	15
Sex and gender differences in neurological infections	15
Recent advances in Alzheimer disease genetics	15
Optic neuritis: current challenges in diagnosis and management	15
The state of art on the use of patient reported outcomes in migraine	14
New insights in the immune treatment of Guillain–Barré syndrome	14
Monitoring multiple sclerosis: digital and fluid phase biomarkers	14
Fluid phase biomarkers in multiple sclerosis	14
Update on genetics of amyotrophic lateral sclerosis	14
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	14
Recent insights in striated muscle laminopathies	14
Current trend in air pollution exposure and stroke	14
Diagnosing viral encephalitis and emerging concepts	14
Visually induced dizziness	14
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	14
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond	14

Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	13
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	13
Advanced neuroimaging techniques in epilepsy	13
Editorial: Making the invisible visible: updates on vestibular neurology	13
Abnormal energy metabolism in ALS: a key player?	13
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders	12
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	12
Current gaps in acute reperfusion therapies	12
Update on modifiable risk factors for Alzheimer's disease and related dementias	12
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	12
Imaging cortical lesions in multiple sclerosis	12
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy	12
Editorial: Seizure disorders: 2023 update	11
Pharmacotherapy of cerebellar and vestibular disorders	11
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	11
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury	11
Peripheral visual field loss and activities of daily living	11
Long COVID and especially headache syndromes	11
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	11
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	11
Interrogating large multiple sclerosis registries and databases: what information can be gained?	11
Motion sickness: current concepts and management	11
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	11
Muscle ultrasound in myopathies	11
Multiple sclerosis: advances and challenges in diagnosis	11
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	11
Therapeutic thoroughfares for adults living with Pompe disease	11
Progression in multiple sclerosis – a long-term problem	10
Progress in treatment of gliomas	10
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success	10
Perception and control of a virtual body in immersive virtual reality for rehabilitation	10
Nonneurologic causes of binocular diplopia for the neurologist	10
Editorial: Cerebrovascular disease	10
Ménière's disease: new guidelines, subtypes, imaging, and more	10
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period	10
An update on psychogenic nonepileptic seizures	10